News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Darvish Nissim
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 20,572 options to buy
@ $1.7, valued at
$35k
Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 10,123 options to buy
@ $0.8, valued at
$8.1k
|
|
| 03/23/2023 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 10,123 options to buy
@ $0.8, valued at
$8.1k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/03/2020 |
4
| Darvish Nissim (10% Owner) has filed a Form 4 on 9 METERS BIOPHARMA, INC.|
Txns:
| Acquired 1,943,734 shares
@ $0 |
|
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Darvish Nissim (10% Owner) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 67,865 convertible preferred
@ $0
Bought 67,865 options to buy
@ $0 |
|
| 05/04/2020 |
4
| Darvish Nissim (10% Owner) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.7, valued at
$35k
|
|
| 05/04/2020 |
3
| Darvish Nissim (10% Owner) has filed a Form 3 on INNOVATE BIOPHARMACEUTICALS, INC. |
|
|